- Filed
- May 18, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 139.84M sh |
| Shares Diluted | Q1 2026 · Mar 28, 2026 | 126.82M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2025 | 15.55M sh |
| Operating Cash Flow | Q1 2026 · Mar 28, 2026 | −$12.29M |
| Operating Cash Flow restated | Q1 2026 · Mar 29, 2025 | −$1.42M |
| Short Term Investments | Q1 2026 · Mar 28, 2026 | $5M |
| Cash And Equivalents | Q1 2026 · Mar 28, 2026 | $10.52M |
| Cash And Equivalents | Q1 2026 · Dec 27, 2025 | $6.22M |
| Stockholders Equity | Q1 2026 · Mar 28, 2026 | $889.74M |
| Stockholders Equity | Q1 2026 · Dec 27, 2025 | $1.15B |
| Current Liabilities | Q1 2026 · Mar 28, 2026 | $39.08M |
| Current Liabilities | Q1 2026 · Dec 27, 2025 | $51.4M |
| Total Liabilities | Q1 2026 · Mar 28, 2026 | $62.6M |
| Total Liabilities | Q1 2026 · Dec 27, 2025 | $60.25M |
| Current Assets | Q1 2026 · Mar 28, 2026 | $32.2M |
| Current Assets | Q1 2026 · Dec 27, 2025 | $29.47M |
| Total Assets | Q1 2026 · Mar 28, 2026 | $959.7M |
| Total Assets | Q1 2026 · Dec 27, 2025 | $1.22B |
| Eps Diluted | Q1 2026 · Mar 28, 2026 | −$2.14 |
| Eps Diluted restated | Q1 2026 · Mar 29, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 28, 2026 | −$2.14 |
| Eps Basic restated | Q1 2026 · Mar 29, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 28, 2026 | $6.32M |
| Sga Expense restated | Q1 2026 · Mar 29, 2025 | $3.87M |
| Net Income | Q1 2026 · Mar 28, 2026 | −$271.49M |
| Net Income restated | Q1 2026 · Mar 29, 2025 | −$2.39M |
| Operating Income | Q1 2026 · Mar 28, 2026 | −$2.74M |
| Operating Income restated | Q1 2026 · Mar 29, 2025 | −$1.95M |
| Gross Profit | Q1 2026 · Mar 28, 2026 | $3.57M |
| Gross Profit restated | Q1 2026 · Mar 29, 2025 | $1.93M |
| Cost Of Revenue | Q1 2026 · Mar 28, 2026 | $1.14M |
| Cost Of Revenue | Q1 2026 · Mar 29, 2025 | $2.92M |
| Revenue | Q1 2026 · Mar 28, 2026 | $4.71M |
| Revenue restated | Q1 2026 · Mar 29, 2025 | $4.85M |